AA
TVTX icon

ALPS Advisors’s Travere Therapeutics TVTX Stock Holding History

ALPS Advisors’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.34M Buy
93,981
+18,885
+25% +$837K 0.03% 264
2026
Q1 		$2.23M Buy
75,096
+1,833
+3% +$54.8K 0.01% 382
2025
Q4 		$2.8M Buy
73,263
+26,020
+55% +$846K 0.02% 338
2025
Q3 		$1.13M Sell
47,243
-705
-1% -$13.3K 0.01% 489
2025
Q2 		$710K Buy
+47,948
New +$795K ﹤0.01% 581
2024
Q2 		– Sell
-53,672
Closed -$414K – 1003
2024
Q1 		$414K Buy
53,672
+6,617
+14% +$55.8K ﹤0.01% 618
2023
Q4 		$423K Sell
47,055
-8,319
-15% -$60.6K ﹤0.01% 637
2023
Q3 		$495K Buy
55,374
+531
+1% +$7.49K ﹤0.01% 599
2023
Q2 		$842K Buy
54,843
+6,731
+14% +$122K 0.01% 525
2023
Q1 		$1.08M Buy
48,112
+4,612
+11% +$98K 0.01% 455
2022
Q4 		$915K Buy
43,500
+8,587
+25% +$182K 0.01% 501
2022
Q3 		$860K Sell
34,913
-2,766
-7% -$71.5K 0.01% 496
2022
Q2 		$913K Sell
37,679
-27,576
-42% -$694K 0.01% 496
2022
Q1 		$1.68M Sell
65,255
-5,599
-8% -$149K 0.02% 258
2021
Q4 		$2.2M Sell
70,854
-3,557
-5% -$100K 0.02% 281
2021
Q3 		$1.8M Sell
74,411
-5,214
-7% -$95.8K 0.02% 331
2021
Q2 		$1.16M Sell
79,625
-29,350
-27% -$579K 0.01% 388
2021
Q1 		$2.72M Buy
108,975
+16,963
+18% +$469K 0.03% 228
2020
Q4 		$2.51M Buy
+92,012
New +$2.15M 0.03% 243

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ALPS Advisors's TVTX Position: Q2 2026 in Review

ALPS Advisors increased its Travere Therapeutics (TVTX) stake by 25% in Q2 2026, buying an estimated $837K and bringing the position to 93,981 shares worth $5.34M. The position accounts for 0.03% of the portfolio, ranked #264.

ALPS Advisors first reported a position in TVTX in Q4 2020 and has held it in 19 quarters since. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • ALPS Advisors held 93,981 shares of Travere Therapeutics worth $5.34M as of Q2 2026.
  • ALPS Advisors bought 18,885 Travere Therapeutics shares in Q2 2026, an estimated $837K.
  • Travere Therapeutics made up 0.03% of ALPS Advisors's portfolio in Q2 2026, its #264 holding.
  • ALPS Advisors first reported a position in Travere Therapeutics in Q4 2020 and has held it in 19 quarters since.
  • 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.